Source:http://linkedlifedata.com/resource/pubmed/id/17401305
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2007-4-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1530-6550
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S1-2
|
pubmed:meshHeading |
pubmed-meshheading:17401305-Coronary Disease,
pubmed-meshheading:17401305-Fibrinolytic Agents,
pubmed-meshheading:17401305-Graft Occlusion, Vascular,
pubmed-meshheading:17401305-Humans,
pubmed-meshheading:17401305-Myocardial Infarction,
pubmed-meshheading:17401305-Thrombolytic Therapy,
pubmed-meshheading:17401305-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Clinical challenges in the prevention and treatment of late and very late stent thrombosis. Introduction.
|
pubmed:affiliation |
Swedish Heart & Vascular Institute, Seattle, Washington, USA.
|
pubmed:publicationType |
Introductory Journal Article
|